US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DAMORA THERAPEUT

30.75

-0.0750-0.24%

Volume:217.95K

Turnover:6.71M

Market Cap:1.89B

PE:-3.11

High:31.49

Open:30.75

Low:29.70

Close:30.82

52wk High:38.33

52wk Low:2.45

Shares:61.55M

Float Shares:47.65M

Volume Ratio:0.78

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.8764

EPS(LYR):-153.9532

ROE:-99.74%

ROA:-21.61%

PB:4.90

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Company Profile

Company Name:

DAMORA THERAPEUT

Exchange:

NASDAQ

Establishment Date:

2011

Employees:

7

Office Location:

Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States

Website:

http://www.damoratx.com

Zip Code:

02453

Phone:

Fax:

- -

Introduction:

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Directors

Name

Position

Carl Goldfischer

Director and Chair of the Board

Amit D. Munshi

Director

Chris Cain

Director

Jayson Dallas

Director

Julianne Bruno

Director

Peter Harwin

Director

Shareholders

Name

Position

Sherwin Sattarzadeh

Chief Operating Officer and Interim Principal Executive Officer

Lori Firmani

Interim Chief Financial Officer

Garrett Winslow

General Counsel

Matthew Kronmiller

Executive Vice President of Strategy and Chief Business Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/DMRA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":30.745,"timestamp":1787597081344,"preClose":30.82,"halted":0,"volume":217953,"delay":0,"changeRate":-0.0024334847501622093,"floatShares":47648701,"shares":61553200,"eps":-9.876431,"marketStatus":"Trading","change":-0.075,"latestTime":"08-24 14:44:58 EDT","open":30.75,"high":31.4942,"low":29.7,"amount":6709195.544139,"amplitude":0.058215,"askPrice":30.85,"askSize":300,"bidPrice":30.71,"bidSize":11,"shortable":3,"etf":0,"ttmEps":-9.876431,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":30.82,"preHourTrading":{"tag":"盘前","latestPrice":30.874,"preClose":30.82,"latestTime":"08:14 EDT","volume":54,"amount":1664.334,"timestamp":1787573662148,"change":0.054,"changeRate":0.001752,"amplitude":0.001752},"postHourTrading":{"tag":"盘后","latestPrice":30.82,"preClose":30.82,"latestTime":"19:30 EDT","volume":2922,"amount":90051.84,"timestamp":1787355006251,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.783741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":47648701,"roa":"-21.61%","roe":"-99.74%","lyrEps":-153.953213,"volumeRatio":0.783741,"shares":61553200,"dividePrice":0,"high":31.4942,"amplitude":0.058215,"preClose":30.82,"low":29.7,"week52Low":2.45,"pbRate":"4.90","week52High":38.3251,"institutionHeld":0,"latestPrice":30.745,"committee":-0.92926,"eps":-9.876431,"divideRate":0,"volume":217953,"delay":0,"ttmEps":-9.876431,"open":30.75,"prevYearClose":23.01,"prevWeekClose":30.82,"prevMonthClose":28.99,"prevQuarterClose":26.01,"fiveDayClose":31.09,"twentyDayClose":29.44,"sixtyDayClose":24.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"DMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1785124800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-08-21","current":-3.11651,"percent":0.571429,"low":-100.260711,"twenty":-7.785196,"median":-7.218207,"eighty":-6.321676,"high":-5.207587,"avg":-13.023094,"sd":22.005777,"marketCap":1871203580},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382},{"date":"2026-03-27","current":-7.36551,"twenty":-98.861547,"median":-80.41388,"eighty":-7.003988,"marketCap":1545571323},{"date":"2026-04-02","current":-7.207452,"twenty":-96.587906,"median":-7.443103,"eighty":-7.019507,"marketCap":1512404556},{"date":"2026-04-10","current":-7.670132,"twenty":-94.238224,"median":-7.361199,"eighty":-7.021806,"marketCap":1609492728},{"date":"2026-04-17","current":-7.759219,"twenty":-89.113027,"median":-7.443103,"eighty":-7.088477,"marketCap":1628186724},{"date":"2026-04-24","current":-7.305161,"twenty":-78.931071,"median":-7.519258,"eighty":-7.200555,"marketCap":1532907649},{"date":"2026-05-01","current":-7.374132,"twenty":-59.951712,"median":-7.420112,"eighty":-7.071235,"marketCap":1547380419},{"date":"2026-05-08","current":-7.181588,"twenty":-7.748873,"median":-7.369821,"eighty":-7.098823,"marketCap":1506977267},{"date":"2026-05-15","current":-6.125513,"twenty":-7.702318,"median":-7.328151,"eighty":-6.979849,"marketCap":1440040702},{"date":"2026-05-22","current":-6.376895,"twenty":-7.679328,"median":-7.296539,"eighty":-6.874668,"marketCap":1499137850},{"date":"2026-05-29","current":-6.50384,"twenty":-7.670132,"median":-7.208889,"eighty":-6.624282,"marketCap":1528981338},{"date":"2026-06-05","current":-5.841412,"twenty":-7.647141,"median":-7.181588,"eighty":-6.506459,"marketCap":1373251758},{"date":"2026-06-12","current":-5.592674,"twenty":-7.644267,"median":-7.103996,"eighty":-6.310202,"marketCap":1314776223},{"date":"2026-06-18","current":-5.608384,"twenty":-7.605184,"median":-7.036462,"eighty":-6.158347,"marketCap":1318469415},{"date":"2026-06-26","current":-5.909488,"twenty":-7.595413,"median":-6.974676,"eighty":-5.98699,"marketCap":1389255588},{"date":"2026-07-02","current":-7.092956,"twenty":-7.5092,"median":-6.96318,"eighty":-6.007936,"marketCap":1667476025},{"date":"2026-07-10","current":-8.059107,"twenty":-7.645417,"median":-7.006288,"eighty":-6.078901,"marketCap":1894607311},{"date":"2026-07-17","current":-7.917719,"twenty":-7.67473,"median":-7.092956,"eighty":-6.150138,"marketCap":1861368586},{"date":"2026-07-24","current":-7.637561,"twenty":-7.776537,"median":-7.12986,"eighty":-6.183485,"marketCap":1795506668},{"date":"2026-07-31","current":-7.648035,"twenty":-7.738833,"median":-7.190209,"eighty":-6.195797,"marketCap":1797968796},{"date":"2026-08-07","current":-7.82346,"twenty":-7.815082,"median":-7.208161,"eighty":-6.219919,"marketCap":1839209436},{"date":"2026-08-14","current":-7.218207,"twenty":-7.815082,"median":-7.209243,"eighty":-6.276357,"marketCap":1897132498},{"date":"2026-08-21","current":-7.119553,"twenty":-7.785196,"median":-7.218207,"eighty":-6.321676,"marketCap":1871203580}],"updateTime":1787594124346},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":154090027,"yearFounded":2011,"employeeNum":7,"address":"Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"781 281 9020","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.damoratx.com","stockEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.0277},{"period":"3month","weight":0.2182},{"period":"6month","weight":0.0273},{"period":"1year","weight":8.1183},{"period":"ytd","weight":0.3394}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.139908},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.041874},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.108508},{"month":4,"riseRate":0,"avgChangeRate":-0.108399},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.014529},{"month":6,"riseRate":0.666667,"avgChangeRate":0.06096},{"month":7,"riseRate":0.5,"avgChangeRate":0.044864},{"month":8,"riseRate":0.5,"avgChangeRate":-0.092277},{"month":9,"riseRate":0.6,"avgChangeRate":0.012323},{"month":10,"riseRate":0.4,"avgChangeRate":0.0502},{"month":11,"riseRate":0.5,"avgChangeRate":0.174574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.010261}],"exchange":"NASDAQ","name":"DAMORA THERAPEUT","nameEN":"DAMORA THERAPEUT"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":{"directors":[{"name":"Carl Goldfischer","position":"Director and Chair of the Board"},{"name":"Amit D. Munshi","position":"Director"},{"name":"Chris Cain","position":"Director"},{"name":"Jayson Dallas","position":"Director"},{"name":"Julianne Bruno","position":"Director"},{"name":"Peter Harwin","position":"Director"}],"executives":[{"name":"Sherwin Sattarzadeh","position":"Chief Operating Officer and Interim Principal Executive Officer"},{"name":"Lori Firmani","position":"Interim Chief Financial Officer"},{"name":"Garrett Winslow","position":"General Counsel"},{"name":"Matthew Kronmiller","position":"Executive Vice President of Strategy and Chief Business Officer"}]}}}